Benchmarking of gastric cancer sensitivity to anti-cancer drugs ex vivo as a basis for drug selection in systemic and intraperitoneal therapy

Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas – PRODIGE 19 – FFCD1103 – ADCI002

(2013) Guillaume Piessen et al.   BMC CANCER

Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials

(2013) F. Coccolini et al.   EJSO

FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort

(2013) Marcello Maugeri-Saccà et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone

(2012) Jung Hun Kang et al.   JOURNAL OF CLINICAL ONCOLOGY

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial

(2012) Eric Van Cutsem et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic value of RKIP and p-ERK in gastric cancer

(2012) Yoshitaka Fujimori et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Treatment-related morbidity and toxicity of CRS and oxaliplatin-based HIPEC compared to a mitomycin and doxorubicin-based HIPEC protocol in patients with peritoneal carcinomatosis: A matched-pair analysis

(2012) Gabriel Glockzin et al.   JOURNAL OF SURGICAL ONCOLOGY

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial

(2011) Xiao-Jun Yang et al.   ANNALS OF SURGICAL ONCOLOGY

Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer

(2011) Taekyu Lim et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer

(2011) Eliza Hawkes et al.   EUROPEAN JOURNAL OF CANCER

An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer

(2011) M. Moehler et al.   EUROPEAN JOURNAL OF CANCER

Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy

(2010) Olivier Glehen et al.   ANNALS OF SURGICAL ONCOLOGY

Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy

(2010) Olivier Glehen et al.   CANCER

Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial

(2010) Michael Gubanski et al.   Gastric Cancer

A multicenter, phase II study of Bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma

(2010) Manish A. Shah et al.   INVESTIGATIONAL NEW DRUGS

Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer

(2010) Chul Kim et al.   INVESTIGATIONAL NEW DRUGS

Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study

(2010) Jean-Yves Douillard et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil With Bevacizumab in Patients With Metastatic Gastroesophageal Adenocarcinoma

(2010) Manish A. Shah et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer-associated fibroblasts are positively correlated with metastatic potential of human gastric cancers

(2010) Kangkang Zhi et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Individualized Tumor Response Testing for Prediction of Response to Paclitaxel and Cisplatin Chemotherapy in Patients with Advanced Gastric Cancer

(2010) Jee Hyun Kim et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

Efficacy of irinotecan in combination with 5-fluorouracil (FOLFIRI) for metastatic gastric or gastroesophageal junction adenocarcinomas (MGA) treatment

(2010) E. Samalin et al.   Clinics and Research in Hepatology and Gastroenterology

Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French Study

(2009) Dominique Elias et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma

(2009) Luigi Di Lauro et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery

(2009) Yutaka Yonemura et al.   JOURNAL OF SURGICAL ONCOLOGY

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

(2008) Leonard B. Saltz et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie

(2008) Salah-Eddin Al-Batran et al.   JOURNAL OF CLINICAL ONCOLOGY

The fluorometric microculture cytotoxicity assay

(2008) Elin Lindhagen et al.   Nature Protocols